D–A Type NIR‐II Organic Molecules: Strategies for the Enhancement Fluorescence Brightness and Applications in NIR‐II Fluorescence Imaging‐Navigated Photothermal Therapy

• Published in: Advanced healthcare materials Vol. 11; no. 21; pp. e2201158 - n/a
• Main Authors: Chen, Yan, Chen, Shangyu, Yu, Haoli, Wang, Yuesong, Cui, Mengyuan, Wang, Peng, Sun, Pengfei, Ji, Min
• Format: Journal Article
• Language: English
• Published: Germany Wiley Subscription Services, Inc 01.11.2022
• Subjects: Brightness; Cell Line, Tumor; Chemotherapy; Design; D–A type organic molecules; Fluorescence; fluorescence brightness enhancement; Guidelines; Medical imaging; Nanoparticles - chemistry; NIR‐II fluorescence imaging; Optical Imaging; Organic chemistry; Phototherapy; Photothermal Therapy; Polymers; Polymers - chemistry; Tumors; NIR-II fluorescence imaging; fluorescence brightness enhancement; D-A type organic molecules; photothermal therapy
• ISSN: 2192-2640; 2192-2659; 2192-2659
• DOI: 10.1002/adhm.202201158

NIR‐II fluorescence imaging (NIR‐II FI) and photothermal therapy (PTT) have received broad attentions in precise tumor diagnosis and effective treatment attributed to high‐resolution and deep tissue imaging, negligible invasivity, and high‐efficiency treatment. Although many fluorescent molecules have been designed and conducted for NIR‐II FI and PTT, it is still an enormous challenge for researchers to pioneer some rational design guidelines to improve fluorescence brightness. Organic D–A‐type molecules, including small molecules and conjugated polymers, can be designed and developed to improve fluorescence brightness due to their tunable and easy functionalized chemical structures, allowing molecules tailored photophysical properties. In this review, some approaches to the development and design strategies of D–A type small molecules and conjugated polymers for the enhancement of fluorescence brightness are systemically introduced. Meanwhile, some applications of PTT and PTT‐based combination therapy (such as PDT, chemotherapy, or gas therapy) assisted by NIR‐II FI‐based single or multiimaging technologies are classified and represented in detail as well. Finally, the current issues and challenges of NIR‐II organic molecules in NIR‐II FI‐navigated PTT are summarized and discussed, which gives some guidelines for the future development direction of NIR‐II organic molecules for NIR‐II FI‐navigated PTT. In this review, some approaches to the development and design strategies of D–A type small molecules and conjugated polymers for the enhancement of fluorescence brightness are systemically introduced. Meanwhile, some applications of photothermal therpy (PTT) and PTT‐based combination therapies assisted by NIR‐II FI‐based single or multiimaging technologies are classified and represented in detail. Finally, the current issues and challenges of NIR‐II organic molecules in NIR‐II FI‐navigated PTT are summarized and discussed.